Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM) (NCT05700994) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
United States1,283 participantsStarted 2023-11-13
Plain-language summary
The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of methamphetamine (MA) harm reduction services.
Who can participate
Age range
18 Years – 105 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
This intervention is at the site level. Community-based organization sites are eligible if they:
* Use peer support specialists to provide direct outreach and harm reduction services to people who use drugs
* Are willing to be trained in the two strategies for peer-facilitated contingency management
Clients who:
* Age 18 and older
* Any stimulant (methamphetamine, cocaine) use in the past 30 days
* Willing to accept peer services
* Willing to complete initial and follow-up assessments with peer
* Able to communicate in English or Spanish
Exclusion Criteria:
Community-based organization sites who:
* Do not use peer support specialists to provide direct outreach and harm reduction services to people who use drugs
* Are not willing to be trained in the two strategies for peer-facilitated contingency management
Clients who:
• Present any danger or threat of violence to peers
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of participants who overdose
Timeframe: 6 months from baseline
2
Number of participants who achieve self-identified goals
Timeframe: 6 months from baseline
3
Number of participants who engage in substance use disorder treatment